Continuous neostigmine infusion versus bolus neostigmine in refractory Ogilvie syndrome.
White
Luke
L
Department of Internal Medicine, St. Luke's-Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, NY, USA. luke@kesil.com
Sandhu
Gagangeet
G
D002800:Cholinesterase Inhibitors / Q000008:administration & dosage* / Q000627:therapeutic use; D003112:Colonic Pseudo-Obstruction / Q000188:drug therapy*; D006801:Humans; D007262:Infusions, Intravenous; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009388:Neostigmine / Q000008:administration & dosage* / Q000627:therapeutic use; D016896:Treatment Outcome
D002800:Cholinesterase Inhibitors; D009388:Neostigmine